JPY2,484.50
0.20% yesterday
Tokyo, Jun 13, 08:14 am CET
ISIN
JP3256000005
Symbol
4151
Index
Sector
Industry

Kyowa Kirin Stock price

JPY2,489.50
+271.50 12.24% 1M
+76.50 3.17% 6M
+114.00 4.80% YTD
-196.50 7.32% 1Y
-235.50 8.64% 5Y
+809.50 48.18% 10Y
+1,782.50 252.12% 20Y
Tokyo, Closing price Fri, Jun 13 2025
+0.00 0.00%
ISIN
JP3256000005
Symbol
4151
Index
Sector
Industry

Key metrics

Market capitalization JPY1.30t
Enterprise Value JPY1.08t
P/E (TTM) P/E ratio 25.35
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.18
P/S ratio (TTM) P/S ratio 2.62
P/B ratio (TTM) P/B ratio 1.57
Dividend yield 2.41%
Last dividend (FY25) JPY60.00
Revenue growth (TTM) Revenue growth 8.90%
Revenue (TTM) Revenue JPY494.71b
EBIT (operating result TTM) EBIT JPY77.66b
Free Cash Flow (TTM) Free Cash Flow JPY-54.39b
Cash position JPY215.56b
EPS (TTM) EPS JPY98.21
P/E forward 21.97
P/S forward 2.72
EV/Sales forward 2.27
Show more

Is Kyowa Kirin a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Kyowa Kirin Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Kyowa Kirin forecast:

5x Buy
56%
3x Hold
33%
1x Sell
11%

Analyst Opinions

9 Analysts have issued a Kyowa Kirin forecast:

Buy
56%
Hold
33%
Sell
11%

Financial data from Kyowa Kirin

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
494,713 494,713
9% 9%
100%
- Direct Costs 131,614 131,614
12% 12%
27%
363,099 363,099
8% 8%
73%
- Selling and Administrative Expenses 166,325 166,325
10% 10%
34%
- Research and Development Expense 108,786 108,786
38% 38%
22%
102,940 102,940
7% 7%
21%
- Depreciation and Amortization 25,278 25,278
131% 131%
5%
EBIT (Operating Income) EBIT 77,662 77,662
23% 23%
16%
Net Profit 51,404 51,404
38% 38%
10%

In millions JPY.

Don't miss a Thing! We will send you all news about Kyowa Kirin directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It operates through the Pharmaceuticals and Bio-Chemicals segments. The Pharmaceuticals segment deals with the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. The Bio-Chemicals segment produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Masashi Miyamoto
Employees 5,669
Founded 1949
Website www.kyowakirin.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today